Category Archives: Myocardial Infarction

The newly added research report on the Myocardial Infarction Drug market is a complete guide to understand various factors that play a crucial role in growth progression. The report is designed to aid the investment decisions and motivate crucial investment discretion for new businesses looking out for seamless market penetration. Report on Myocardial Infarction Drug Market is a comprehensive study that deals with the status and position globally and provides DROC analysis for changing competitive dynamics and different factors driving or restraining industry growth. Continue reading →

Patients with rheumatoid arthritis (RA) are at increased risk for ischemic and non-ischemic heart disease, secondary to subclinical pathological changes in heart muscle and in coronary vessels, according to a review published in Rheumatic & Musculoskeletal Diseases. Systemic inflammation is a risk factor for cardiovascular disease (CVD) and treatment with conventional and biologic antirheumatic medications may have a significant impact on cardiovascular (CV) outcomes.1 Previous studies have established RA is an independent risk factor for premature atherosclerosis and reported that patients with RA are at an increased risk for CV events and cardiac mortality, compared with the general population.2-4 Chronic systemic inflammation secondary to rheumatic diseases is an important contributor for the increased CV risk among patients with RA and is associated with arterial stiffness, lipid-salvage mechanisms, and destabilization of plaques.4 Disease activity significantly affects CV risk, as each period of increased joint disease activity is associated with a 7% increased CV risk, while a low disease activity reduces the CV risk.5,6 Several proinflammatory cytokines have been associated with inflammation in RA and with pathogenesis of heart disease, including tumor necrosis factor-alpha, interleukin (IL)-1, IL-6 and IL-17.1 While the contribution of inflammation to atherosclerosis and ischemic heart disease is well described, the mechanisms responsible for non-ischemic heart disease is less well understood. In addition to inflammation, traditional CV risk factors, including hypertension, diabetes, dyslipidemia, obesity, smoking, family history and physical inactivity, may be more common among patients with RA, compared with the general population.7 Patients with RA were found to be at increased risk for myocardial infarction, major CV events and all-cause mortality, regardless of the presence of coronary artery disease (CAD) Continue reading →

Department of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, Peoples Republic of China Correspondence: Zening Jin Department of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, No. 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, Peoples Republic of China Email Jin_zening@163.com Introduction: The efficacy of fibrinolysis therapy with deferred percutaneous coronary angioplasty (FPCI) versus primary angioplasty (PPCI) during the coronavirus disease 2019 (COVID-19) pandemic is unclear when medical quarantine is needed. Patients and Methods: Acute ST segment elevation myocardial infarction (STEMI) patients underwent PPCI after finishing the screening protocol from January 23, 2020 to June 10, 2020 while FPCI was applied when COVID-19-confirmed cases reoccurred in Beijing near our hospital from June 11, 2020 to July 20, 2020. Continue reading →

Health Ministry says death of a person from Shivamogga in Karnataka is not related to vaccination, and it's a case of myocardial infarction, commonly known as a heart attack A man from Shivamogga area of Karnataka was the second recipient to die after taking Covid-19 vaccine. The health ministry confirmed the death of the recipient but said it's not related to vaccination. The Union Health Ministry in a statement said the death of a person from Shivamogga in Karnataka is not related to vaccination, and that it's a case of myocardial infarction (MI), commonly known as a heart attack Continue reading →

Cardiac rehabilitation program is well-established but the Rehabilitation After Myocardial Infarction Trial (RAMIT) is reported that it does not affect mortality and morbidity of patients after myocardial infarction during follow-up period. The objectives of the study were to compare functional walking capacity, risk factor control, and morbidities in follow-up for cardiac rehabilitation (exercise + education), exercise only, and usual care among patients with coronary artery disease Continue reading →

Market Overview: This market research report provides a comprehensive picture on Myocardial Infarction Drugs Market, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases Continue reading →

Global Myocardial Infarction Market Research Report 2020 offers thorough analysis about the key market players. The section reveals detailed information of the company covering profile, business overview, sales data as well as product specifications that enables in forecasting the business. The report on Myocardial Infarction Market, offers valuable deep insights for global market based upon the significant aspects of a market investigation Continue reading →

Nearly pain-free microneedle patch can test for antibodies and more in the fluid between cells Engineers at the McKelvey School of Engineering at Washington University in St. Louis have developed a microneedle patch that can be applied to the skin, capture a biomarker of interest from interstitial fluid and, thanks to its unprecedented sensitivity, allow clinicians to detect its presence.(Image: Sisi Cao) Blood draws are no fun Continue reading →

This article was originally published here Am J Cardiol. Continue reading →

Fort Collins, Colorado: Reports Globe has published the latest study on Myocardial Infarction Treatment Market Report Analysis by Size with Future Outlook, Key Players SWOT Analysis and Forecast to 2026. It uses exploratory techniques such as qualitative and quantitative analysis to identify and present data on the target market. Successful sales strategies have been mentioned that will help you do business in record time and multiply customers Continue reading →